Pfizer/BioNTech and Moderna have both developed shots that use a piece of genetic code from SARS-CoV-2, the coronavirus that causes COVID-19, to prompt an immune response in recipients (here). However, experts told Reuters that this is not the same as gene therapy.
“As mRNA is genetic material, mRNA vaccines can be looked at as a genetic-based therapy, but they are classified as vaccines and are not designed to alter your genes,” said Dr Adam Taylor, a virologist and research fellow at the Menzies Health Institute, Queensland, Griffith University.
“Gene therapy, in the classical sense, involves making deliberate changes to a patient’s DNA in order to treat or cure them. mRNA vaccines will not enter a cell’s nucleus that houses your DNA genome. There is zero risk of these vaccines integrating into our own genome or altering our genetic makeup.”
Taylor explained that mRNA enters cells shortly after vaccination and instructs them to create a SARS-CoV-2 spike protein, prompting the immune response.
He added that unlike gene therapy, mRNA vaccines are then “rapidly degraded” by the body.
“In fact, because mRNA is degraded so quickly chemical modifications can be made to mRNA vaccines to make them a little more stable than regular mRNA.”
Gene therapy, on the other hand, involves a process whereby an individual’s genetic makeup is deliberately modified to cure or treat a specific genetic condition (here).
It can be done in several ways, such as replacing a disease-causing gene with a healthy alternative, disabling a disease-causing gene or introducing a new gene to help treat a disease, according to the U.S. Food and Drug Administration (FDA)
VERDICT
Missing context. Scientists told Reuters that while mRNA vaccines can be considered “genetic-based therapy” because they use genetic code from COVID-19, they are not technically gene therapy. This is because the mRNA does not change the body’s genetic makeup.